Merck Raises 2022 Forecast As COVID Pill, Cancer Drug Fuels Profit Beat. NetChatTVApril 30, 2022Cancer Drug, COVID Drug, Covid Shot, COVID-19, Drugs, Health, Health Care, Health Issues, Medical, Medical Issues, Medical News, Merck, Netchattv, News, Pharmaceuticals, US News, World News Post navigation PreviousNext April 30, 2022 Merck Raises 2022 Forecast as COVID Pill, Cancer Drug Fuels Profit Beat https://t.co/cd2a8QUht0 via @epochtimes— NetChatTV (@NetChatTV) April 30, 2022 Share this:TwitterFacebookLike this:Like Loading... Related